As of March 2025, 503A and 503B pharmacies can no longer compound injectable tirzepatide under the shortage exception
We can also help decrease your uncomfortable symptoms by readjusting your medication regimen as needed
Prescriptions for compounded tirzepatide, when available, may be prescribed as an alternative to commercially unavailable branded medications on the FDA shortage list
DoctorAdam is available in most U.S
Genetic predispositions do not predict exact medication response, but they may reveal whether you have favorable receptor pathways (suggesting lower-cost, lower-dose options may work well) or less favorable variants (suggesting dual-agent or higher-dose compounds may offer better clinical return on investment)
Combination formulations with B12 , glycine , or levocarnitine add $15 to $50 per month